(NP (NP Replication/NN) (PP of/IN (NP (NP type/NN 1/CD human/JJ immunodeficiency/NN viruses/NNS) (VP containing/VBG (NP linker/NN substitution/NN mutations/NNS) (PP in/IN (NP (NP the/DT (NP-COOD (NP -201/CD) to/TO (NP -130/CD)) (NP region/NN)) (PP of/IN (NP the/DT long/JJ terminal/JJ repeat/NN))))))) ./.)
(S (PP In/IN (NP (NP previous/JJ transfection/NN analyses/NNS) (VP using/VBG (NP the/DT chloramphenicol/JJ acetyltransferase/NN reporter/NN gene/NN system/NN)))) ,/, (NP-SBJ we/PRP) (VP determined/VBD (SBAR that/IN (S (NP-SBJ (NP (NP (NP linker/NN substitution/NN) (PRN -LRB-/-LRB- (NP LS/NN) -RRB-/-RRB-)) mutations/NNS) (PP between/IN (NP (NP-COOD (NP -201/CD) and/CC (NP -130/CD)) -LRB-/-LRB- (ADJP relative/JJ (PP to/TO (NP the/DT transcription/NN start/NN site/NN))) -RRB-/-RRB- (PP of/IN (NP the/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (NP (NP long/JJ terminal/JJ repeat/NN) (PRN -LRB-/-LRB- (NP LTR/NN) -RRB-/-RRB-))))))) (VP caused/VBD (NP (NP moderate/JJ decreases/NNS) (PP in/IN (NP (NP LTR/NN transcriptional/JJ activity/NN) (PP in/IN (NP a/DT T-cell/NN line/NN)))))))) (PRN -LRB-/-LRB- (FRAG (NP-COOD (NP S.L.Zeichner/NNP) ,/, (NP J.Y.H./NNP Kim/NNP) ,/, and/CC (NP J.C.Alwine/NNP) ,/, (NP J.Virol.65/NNP)) :/: (NP 2436-2444/CD) ,/, (NP 1991/CD)) -RRB-/-RRB-)) ./.)
(S (SBAR In/IN order/NN to/TO (S (NP-SBJ *-56/-NONE-) (VP confirm/VB (NP (NP the/DT significance/NN) (PP of/IN (NP this/DT region/NN)) (PP in/IN (NP (NP the/DT context/NN) (PP of/IN (NP viral/JJ replication/NN)))))))) ,/, (NP-SBJ-56 we/PRP) (VP-COOD (VP constructed/VBD (NP (NP (NP (NP several/JJ) (PP of/IN (NP these/DT LS/NN mutations/NNS))) (PRN -LRB-/-LRB- (NP-COOD (NP-COOD (NP -201/CD) to/TO (NP - 184/CD)) ,/, (NP-COOD (NP -183/CD) to/TO (NP -166/CD)) ,/, (NP-COOD (NP -165/CD) to/TO (NP -148/CD)) ,/, and/CC (NP-COOD (NP -148/CD) to/TO (NP -130/CD))) -RRB-/-RRB-)) (PP in/IN (NP proviruses/NNS)))) and/CC (VP prepared/VBD (NP viral/JJ stocks/NNS) (PP by/IN (NP (NP cocultivation/NN) (PP of/IN (NP transfected/VBN RD/NN cells/NNS)) (PP with/IN (NP CEMx174/NN cells/NNS)))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ-57 (NP two/CD mutations/NNS) (PP-COOD (PP between/IN (NP-COOD (NP -93/CD) and/CC (NP -76/CD))) and/CC (PP between/IN (NP-COOD (NP -75/CD) and/CC (NP -58/CD))))) (VP were/VBD (VP utilized/VBN (NP *-57/-NONE-) ,/, (SBAR since/IN (S (NP-SBJ-58 they/PRP) (VP-COOD (VP affect/VBP (NP the/DT (ADJP-COOD (ADJP (NP (NP nuclear/JJ factor/NN kappa/NN B/NN) (PRN -LRB-/-LRB- (NP NF-kappa/NN B/NN) -RRB-/-RRB-) -/:) (ADJP *?*/-NONE-)) and/CC (ADJP Sp1-binding/JJ)) sites/NNS)) and/CC (VP were/VBD (VP expected/VBN (S (NP-SBJ *-58/-NONE-) (VP to/TO (VP diminish/VB (NP viral/JJ replication/NN))))))))))) ./.)
(S (NP-SBJ Our/PRP$ results/NNS) (VP suggest/VBP (SBAR that/IN (S (SBAR while/IN (S (NP-SBJ transfection/NN analyses/NNS) (VP offer/VBP (NP (NP an/DT adequate/JJ approximation/NN) (PP of/IN (NP (NP the/DT effects/NNS) (PP of/IN (NP the/DT LS/NN mutations/NNS)))))))) ,/, (NP-SBJ (NP the/DT analysis/NN) (PP of/IN (NP (NP viral/JJ replication/NN) (VP using/VBG (NP a/DT mutant/JJ viral/JJ stock/NN))))) (VP presents/VBZ (NP (NP a/DT (ADJP more/RBR accurate/JJ) picture/NN) ,/, (SBAR (WHNP-59 which/WDT) (S (NP-SBJ *T*-59/-NONE-) (VP is/VBZ (ADVP-TMP sometimes/RB) (PP-PRD at/IN variance/NN with/IN (NP the/DT transfection/NN results/NNS)))))))))) ./.)
(S-COOD (S (NP-SBJ (NP Three/CD mutants/NNS) (PRN -LRB-/-LRB- (NP-COOD (NP -201\/-184/CD NXS/NN) ,/, (NP -165\/-148/CD NXS/NN) ,/, and/CC (NP -147\/-130/CD NXS/NN)) -RRB-/-RRB-)) (VP had/VBD (NP (NP effects/NNS) (SBAR *ICH*-102/-NONE-)) (PP on/IN (NP viral/JJ replication/NN)) (SBAR-102 (WHNP-60 that/WDT) (S (NP-SBJ *T*-60/-NONE-) (VP were/VBD (ADJP-PRD (ADJP (ADVP much/RB more/RBR) severe/JJ) (PP than/IN (NP (NP the/DT effects/NNS) (VP predicted/VBN (NP */-NONE-) (PP from/IN (NP (NP their/PRP$ performance/NN) (PP in/IN (NP transfection/NN analyses/NNS))))))))))))) ,/, and/CC (S (NP-SBJ-61 (NP the/DT effects/NNS) (PP of/IN (NP (NP two/CD LS/NN mutations/NNS) (PRN -LRB-/-LRB- (NP-COOD (NP -201\/-184/CD NXS/NN) and/CC (NP -183\/-166/CD NXS/NN)) -RRB-/-RRB-)))) (VP were/VBD not/RB (VP predicted/VBN (NP *-61/-NONE-) (PP by/IN (NP (NP their/PRP$ effects/NNS) (PP in/IN (NP transfection/NN))))))) ./.)
(S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ we/PRP) (VP observed/VBD (NP (NP (ADJP cell/NN type-specific/JJ) permissiveness/NN) (PP to/TO (NP (NP replication/NN) (PP of/IN (NP some/DT mutant/JJ viruses/NNS)))))) ./.)
(S (PP In/IN (NP (NP the/DT cell/NN types/NNS) (VP tested/VBN (NP */-NONE-)))) ,/, (NP-SBJ the/DT LS/NN mutations/NNS) (VP indicated/VBD (NP (NP an/DT apparent/JJ requirement/NN) (PP-COOD (CONJP not/RB only/RB) (PP for/IN (NP the/DT intact/JJ (ADJP-COOD (ADJP (NP NF-kappa/NN B/NN) (ADJP *?*/-NONE-)) and/CC (ADJP SP1-binding/JJ)) sites/NNS)) (CONJP but/CC also/RB) (PP for/IN (NP (NP several/JJ regions/NNS) (PP between/IN (NP-COOD (NP -201/CD) and/CC (NP -130/CD))) (VP not/RB (ADVP-TMP previously/RB) associated/VBN (NP */-NONE-) (PP with/IN (NP viral/JJ infectivity/NN)))))))) ./.)
